Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Chronic hepatitis B (HBV) and C virus (HCV) infection causes liver cancer. This protocol is to provide the methods used to assess the relationship between statins and HCC risk in hepatitis B or C patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiguo, Li, Ying, Li, Xiaoke, Zhang, Ludan, Zhao, Nanqi, Du, Hongbo, Zhou, Bo, Ye, Yong’an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112957/
https://www.ncbi.nlm.nih.gov/pubmed/30142817
http://dx.doi.org/10.1097/MD.0000000000011950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112957/
https://www.ncbi.nlm.nih.gov/pubmed/30142817
http://dx.doi.org/10.1097/MD.0000000000011950

Ejemplares similares